Pathogenetic interrelations of hypogonadism and depression in men

Bulanov V.S.; Litvinov A.V.; Gorobets L.N.; Akhmedova A.A.

doi:https://doi.org/10.17116/jnevro202512501117

Recommended articles:

Subjective sleep quality evaluation in patients with neuromyelitis optica spectrum disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):57-61

Nutritional care for patients with neurodegenerative diseases in the outpatient practice of a neurologist. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):76-83

The association of NOS1AP gene polymorphisms with the duration of the QT interval in patients with schizophrenia receiving antipsychotic therapy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):98-104

Clinical and psychopathological features of treatment-resistant schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):43-50

A personalized approach to the treatment of chronic tension headache and comorbid mental disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):51-57

Asthenia in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):5-10

The state of mental health of migrant workers and citizens of the Russian Federation: A comparative analysis as illustrated by the Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):95-101

Atopic dermatitis and skin toxic reactions: comparative characteristics, psychosomatic aspects and patient management tactics. Russian Journal of Clinical Dermatology and Venereology. 2024;(6):744-752

Experience with the use of amitriptyline for chronic pelvic pain associated with endometriosis. Russian Journal of Human Reproduction. 2025;(1):86-93

Abstract:

The study of the relationship between depression and functional hypogonadism in men is an interesting and difficult task. The purpose of the presented review was to identify the problem of functional male hypogonadism, to show a complex multi-stage neurohumoral mechanism of regulation of its potential to influence the affective sphere and to address the influence of pharmacotherapy on the formation of sexual disorders in men. The primary search for literature data was conducted using PubMed (Medline), PsycINFO and Cochrane CENTRAL, e-library.ru, databases using the keywords «hypogonadism», «depression», «testosterone», «antidepressants», «antipsychotics». As a result, 63 sources of information were selected and analyzed. Among the selected papers, there were 2 meta-analyses, 12 reviews and 42 comparative studies, including longitudinal, cross-sectional and controlled studies, 7 practical manuals. Based on the data obtained, it is possible to draw conclusions about the relationship between depression and functional hypogonadism as well as about the possibility of pathogenetic mechanisms of depression to cause changes in the state of the hypothalamic–pituitary–gonadal axis, leading to hypogonadism and vice versa, the ability of hypogonadism to form and enhance depressive symptoms. The concept of the mechanisms of regulation of steroidogenesis can allow the development of alternative methods of therapy and augmentation of depressive disorders, minimization of the number of sexual dysfunctions of psychopharmacotherapy. Further large-scale studies are needed for an in-depth study of this topic and the resolution of a number of contradictions.

Keywords:

hypogonadism

depression

testosterone

antidepressants

antipsychotics

Authors:

Bulanov V.S.

Moscow Research Institute of Psychiatry — Serbsky National Medical Research Center

ORCID: 0000-0002-4603-5642

Litvinov A.V.

Moscow Research Institute of Psychiatry — Serbsky National Medical Research Center

ORCID: 0000-0001-6818-8474

Gorobets L.N.

Moscow Research Institute of Psychiatry — Serbsky National Medical Research Center

ORCID: 0000-0001-7075-1107

Akhmedova A.A.

Moscow Research Institute of Psychiatry — Serbsky National Medical Research Center

ORCID: 0009-0002-8494-1440

Received:

23.04.2024

Accepted:

02.09.2024

Close metadata

References:

Grossmann M, Matsumoto AM. A Perspective on Middle- Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management. J Clin Endocrinol Metab. 2017;102(3):1067-1075. https://doi.org/10.1210/jc.2016-3580
Vornik BM. Testosteron i depressiya: paradoksy i zakonomernosti. XVI S»ezd psihiatrov Rossii. Vserossijskaya nauchno-prakticheskaya konferenciya s mezhdunarodnym uchastiem «Psihiatriya na etapah reform: problemy i perspektivy». Kazan’, 23-26 sentyabrya 2015 goda. Otvetstvennyj redaktor Neznanov NG. Kazan’: OOO «Al’ta Astra». 2015;795. (In Russ.). https://EDNXGKKVT
Osadshij YY, Soldatkin VA, Kryuchkova MN, et al. Depression in men with testosterone deficiency. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(10):19-24. (In Russ.). https://doi.org/10.17116/jnevro202112110119
Mueller SC, Mandell D, Leschek EW, et al. Early hyperandrogenism affects the development of hippocampal function: preliminary evidence from a functional magnetic resonance imaging study of boys with familial male precocious puberty. J Child Adolesc Psychopharmacol. 2009;19(1):41-50. https://doi.org/10.1089/cap.2008.031
Westley CJ, Amdur RL, Irwig MS. High rates of depression and depressive symptoms among men referred for borderline testosterone levels. J Sex Med. 2015;12(8):1753-1760. https://doi.org/10.1111/jsm.12937
Davies RH, Harris B, Thomas DR, et al. Salivary testosterone levels and major depressive illness in men. Br J Psychiatry. 1992;161(5):629-632. https://doi.org/10.1192/bjp.161.5.629
Dedov II, Mel’nichenko GA, Rozhivanov RV, et al. Recommendations for the diagnosis and treatment of testosterone deficiency (hypogonadism) in men. Problems of Endocrinology. 2016;6:78-80. (In Russ.). https://doi.org/10.14341/probl201662678-80
Lunenfeld B, Mskhalaya G, Zitzmann M, et al. Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men. J Int Soc Study Aging Male. 2021;24(1):119-138. https://doi.org/10.1080/13685538.2021.1962840
Takao T, Tsujimura A, Okuda H, et al. Lower urinary tract symptoms and erectile dysfunction associated with depression among Japanese patients with late-onset hypogonadism symptoms. Aging Male. 2011;14(2):110-114. https://doi.org/10.3109/13685538.2010.512374
Barrett-Connor E, Von Mühlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study. J Clin Endocrinol Metab. 1999;84(2):573-577. https://doi.org/10.1210/jcem.84.2.5495
Levitt AJ, Joffe RT. Total and free testosterone in depressed men. Acta Psychiatr Scand. 1988;77(3):346-348. https://doi.org/10.1111/j.1600-0447.1988.tb05132.x
Jayasena CN, Anderson RA, Llahana S, et al. Society for endocrinology guidelines for testosterone replacement therapy in male hypogonadism. Clin Endocrinol (Oxf). 2022;96(2):200-219. https://doi.org/10.1111/cen.14633
O’Donnell L, Stanton P, de Kretser DM. Endocrinology of the male reproductive system and spermatogenesis. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, et al., eds. Endotext. South Dartmouth. MA: MDText.com, Inc; 2000. https://www.ncbi.nlm.nih.gov/books/NBK279031/
Isidori AM, Aversa A, Calogero A, et al. Adult- and late-onset male hypogonadism: the clinical practice guidelines of the Italian Society of Andrology and Sexual Medicine (SIAMS) and the Italian Society of Endocrinology (SIE). J Endocrinol Invest. 2022;45(12):2385-2403. https://doi.org/10.1007/s40618-022-01859-7
Hsu B, Cumming RG, Blyth FM, et al. The longitudinal relationship of sexual function and androgen status in older men: the Concord Health and Aging in Men Project. J Clin Endocrinol Metab. 2015;100(4):1350-1358. https://doi.org/10.1210/jc.2014-4104
Marques P, Skorupskaite K, Rozario KS, et al. Physiology of gnRH and gonadotropin secretion. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, et al., eds. Endotext. South Dartmouth (MA: MDText.com, Inc). 2000. https://www.ncbi.nlm.nih.gov/books/NBK279070/
Nathan FM, Ogawa S, Parhar IS. Kisspeptin1 modulates odorant-evoked fear response via two serotonin receptor subtypes (5-HT1A and 5-HT2) in zebrafish. J Neurochem. 2015;133(6):870-878. https://doi.org/10.1111/jnc.13105
Umathe SN, Bhutada PS, Jain NS, et al. Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats. Behav Pharmacol. 2008;19(4):308-316. https://doi.org/10.1097/FBP.0b013e328308f1fb
Umathe SN, Bhutada PS, Jain NS, et al. Gonadotropin-releasing hormone agonist blocks anxiogenic-like and depressant-like effect of corticotrophin-releasing hormone in mice. Neuropeptides. 2008;42(4):399-410. https://doi.org/10.1016/j.npep.2008.04.005
Comninos AN, Wall MB, Demetriou L, et al. Kisspeptin modulates sexual and emotional brain processing in humans. J Clin Invest.2017;127(2):709-719. https://doi.org/10.1172/JCI89519
Tanaka M, Csabafi K, Telegdy G. Neurotransmissions of antidepressant-like effects of kisspeptin-13. Regul Pept. 2013;180:1-4. https://doi.org/10.1016/j.regpep.2012.08.017
Grossmann M, Wittert GA. Dysregulation of the hypothalamic-pituitary-testicular axis due to energy deficit. J Clin Endocrinol Metab. 2021;106(12):e4861-e4871. https://doi.org/10.1210/clinem/dgab517
Dornbush S, Abddula NR. Physiology, leptin. StatPearls. Treasure Island FL: StatPearls Publishing. 2022. Available at: https://www.ncbi.nlm.nih.gov/books/NBK537038/
Saluhov VV, Ajsaeva SV. Functional hypogonadism in men: the main causes and neuroendocrine mechanisms of its development. Medicinskij sovet. 2024;18(6):112-123. (In Russ.). https://doi.org/10.21518/ms2024-210
Genchi VA, Rossi E, Lauriola C, et al. Adipose Tissue Dysfunction and Obesity-Related Male Hypogonadism. Int J Mol Sci. 2022;23:8194. https://doi.org/10.3390/ijms23158194
Lima TFN, Nackeeran S, Rakitina E, et al. Association of Leptin with Total and Free Testosterone: Results from the National Health and Nutrition Examination Surveys. Androg Clin Res Ther. 2020;1(1):94-100. https://doi.org/10.1089/andro.2020.0007
Roumaud P, Martin LJ. Roles of leptin, adiponectin and resistin in the transcriptional regulation of steroidogenic genes contributing to decreased Leydig cells function in obesity. Horm Mol Biol Clin Investig. 2015;24(1):25-45. https://doi.org/10.1515/hmbci-2015-0046
Choubey M, Ranjan A, Bora PS, et al. Direct actions of adiponectin on changes in reproductive, metabolic, and anti-oxidative enzymes status in the testis of adult mice. Gen Comp Endocrinol. 2019;279:1-11. https://doi.org/10.1016/j.ygcen.2018.06.002
Sahu MK, Dubey RK, Chandrakar A, et al. A systematic review and meta-analysis of serum and plasma cortisol levels in depressed patients versus control. Indian J Psychiatry. 2022;64(5):440-448. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_561_21
Oakley AE, Breen KM, Clarke IJ, et al. Cortisol reduces gonadotropin-releasing hormone pulse frequency in follicular phase ewes: influence of ovarian steroids. Endocrinology. 2009;150(1):341-349. https://doi.org/10.1210/en.2008-0587
Kinsey-Jones JS, Li XF, Knox AMI, et al. Down-regulation of hypothalamic kisspeptin and its receptor, Kiss1r, mRNA expression is associated with stress-induced suppression of luteinising hormone secretion in the female rat. J Neuroendocrinol. 2009;21(1):20-29. https://doi.org/10.1111/j.1365-2826.2008.01807.x
Saketos M, Sharma N, Santoro NF. Suppression of the hypothalamic-pituitary-ovarian axis in normal women by glucocorticoids. Biol Reprod. 1993;49(6):1270-1276. https://doi.org/10.1095/biolreprod49.6.1270
MacQueen G, Frodl T. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research? Mol Psychiatry. 2011;16(3):252-264. https://doi.org/10.1038/mp.2010.80
Beilin J, Ball EM, Favaloro JM, et al. Effect of the androgen receptor CAG repeat polymorphism on transcriptional activity: specificity in prostate and non-prostate cell lines. J Mol Endocrinol. 2000;25(1):85-96. https://doi.org/10.1677/jme.0.0250085
Schneider G, Nienhaus K, Gromoll J, et al. Depressive symptoms in men aged 50 years and older and their relationship to genetic androgen receptor polymorphism and sex hormone levels in three different samples. American Journal of Geriatric Psychiatry. 2011;19(3):274-283. https://doi.org/10.1097/JGP.0b013e3181e70c22
Tremellen K, McPhee N, Pearce K. et al. Endotoxin-initiated inflammation reduces testosterone production in men of reproductive age. Am J Physiol Endocrinol Metab. 2018;314(3):E206-E213. https://doi.org/10.1152/ajpendo.00279.2017
Seftel AD. Male hypogonadism. Part I: epidemiology of hypogonadism. Int J Impot Res. 2006;18(2):115-120. https://doi.org/10.1038/sj.ijir.3901397
Zenebe Y, Akele B, Selassie M, et al. Prevalence and determinants of depression among old age: a systematic review and meta-analysis. Ann Gen Psychiatry. 2021;20(1):55. https://doi.org/10.1186/s12991-021-00375-x
Corona G, Rastrelli G, Maseroli E, et al. Sexual function of the ageing male. Best Pract Res Clin Endocrinol Metab. 2013;27(4):581-601. https://doi.org/10.1016/j.beem.2013.05.007
Giltay EJ, van der Mast RC, Lauwen E, et al. Plasma testosterone and the course of major depressive disorder in older men and women. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2017;25(4):425-437. https://doi.org/10.1016/j.jagp.2016.12.014
Barrett-Connor E, Von Mühlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo study. JClinEndocrinolMetab. 1999;84(2):573-577. https://doi.org/10.1210/jcem.84.2.5495
Mazur A. Biosocial models of deviant behavior among male army veterans. Biol Psychol. 1995;41(3):271-293. https://doi.org/10.1016/0301-0511(95)05138-4
Babenko AY. Age-related androgen deficiency is at the peak of controversy. RMZH. Medicinskoe obozrenie. 2019;3:10(II):92-95. (In Russ.). https://www.rmj.ru/articles/endokrinologiya/Vozrastnoy_deficit_androgenov__na_pike_protivorechiy/#ixzz8gyJzEngo
Smulevich AB. Depressii pri psihicheskih i somaticheskih zabolevaniyah. M.: OOO «Izdatel’stvo «Medicinskoe informacionnoe agentstvo». 2015;640. (In Russ.).
Mazo GE, Neznanov NG. Depressivnoe rasstrojstvo. M.: GEOTAR-Media. 2019;112. (In Russ.).
Bennabi D, Vandel P, Papaxanthis C, et al. Psychomotor retardation in depression: a systematic review of diagnostic, pathophysiologic, and therapeutic implications. BioMed Res Int. 2013;2013:158746. https://doi.org/10.1155/2013/158746
Roshanaei-Moghaddam B, Katon WJ, Russo J. The longitudinal effects of depression on physical activity. Gen Hosp Psychiatry. 2009;31(4):306-315. https://doi.org/10.1016/j.genhosppsych.2009.04.002
Riachy R, McKinney K, Tuvdendorj DR. Various factors may modulate the effect of exercise on testosterone levels in men. J Funct Morphol Kinesiol. 2020;5(4):81. https://doi.org/10.3390/jfmk5040081
Clayton AH, Alkis AR, Parikh NB, et al. Sexual dysfunction due to psychotropic medications. Psychiatr Clin North Am. 2016;39(3):427-463. https://doi.org/10.1016/j.psc.2016.04.006
Stahl SM. The psychopharmacology of sex, part 2: effects of drugs and disease on the 3 phases of human sexual response. J Clin Psychiatry. 2001;62(3):147-148. https://doi.org/10.4088/JCP.v62n0301
Makhlouf A, Kparker A, Niederberger CS. Depression and erectile dysfunction. Urol Clin North Am 2007;34(4):565-574. https://doi.org/10.1016/j.ucl.2007.08.009
Stahl SM. The psychopharmacology of sex, Part 1: Neurotransmitters and the 3 phases of the human sexual response. J Clin Psychiatry. 2001;62(2):80-81. https://doi.org/10.4088/JCP.v62n0201
Bakr AM, El-Sakka AA, El-Sakka AI. Pharmaceutical management of sexual dysfunction in men on antidepressant therapy. Expert Opin Pharmacother. 2022;23(9):1051-1063. https://doi.org/10.1080/14656566.2022.2064218
Serretti A, Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants: A meta-analysis. J Clin Psychopharmacol. 2009;29(3):259-266. https://doi.org/10.1097/JCP.0b013e3181a5233f
Voicu V, Medvedovici A, Ranetti AE, et al. Drug-induced hypo- and hyperprolactinemia: mechanisms, clinical and therapeutic consequences. Expert Opin Drug Metab Toxicol. 2013;9(8):955-968. https://doi.org/10.1517/17425255.2013.791283
Winter J, Curtis K, Hu B, et al. Sexual dysfunction with major depressive disorder and antidepressant treatments: impact, assessment, and management. Expert Opin Drug Saf. 2022;21(7):913-930. https://doi.org/10.1080/14740338.2022.2049753
Trinchieri M, Trinchieri M, Perletti G, et al. Erectile and ejaculatory dysfunction associated with use of psychotropic drugs: A systematic review. J Sex Med. 2021;18(8):1354-1363. https://doi.org/10.1016/j.jsxm.2021.05.016
Angulo J, Peiró C, Sanchez-Ferrer CF, et al. Differential effects of serotonin reuptake inhibitors on erectile responses, NO-production, and neuronal NO synthase expression in rat corpus cavernosum tissue. Br J Pharmacol. 2001;134(6):1190-1194. https://doi.org/10.1038/sj.bjp.0704351
Knegtering H, van der Moolen AE, Castelein S, et al. What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology. 2003;28((Suppl. S2)):109-123. https://doi.org/10.1016/S0306-4530(02)00130-0
Just MJ. The influence of atypical antipsychotic drugs on sexual function. Neuropsychiatr Dis Treat. 2015;11:1655-1661. https://doi.org/10.2147/NDT.S84528
Montejo AL, Montejo L, Navarro-Cremades F. Sexual side-effects of antidepressant and antipsychotic drugs. Curr Opin Psychiatry. 2015;28:418-423. https://doi.org/10.1097/YCO.0000000000000198
Serretti A, Chiesa A. A meta-analysis of sexual dysfunction in psychiatric patients taking antipsychotics. Int Clin Psychopharmacol. 2011;26(3):130-140. https://doi.org/10.1097/YIC.0b013e328341e434
Hunter RH, Joy CB, Kennedy E, et al. Risperidone versus typical antipsychotic medication for schizophrenia. Cochrane Database Syst Rev. 2003;(2):CD000440. https://doi.org/10.1002/14651858.CD000440